We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+4.69%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$15.2B
AUM Growth
+$1.14B
Cap. Flow
+$754M
Cap. Flow %
4.96%
Top 10 Hldgs %
15.87%
Holding
1,269
New
352
Increased
317
Reduced
269
Closed
320

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$124M
2
TXN icon
Texas Instruments
TXN
+$113M
3
UNH icon
UnitedHealth
UNH
+$106M
4
PM icon
Philip Morris
PM
+$106M
5
TJX icon
TJX Companies
TJX
+$93.3M

Sector Composition

Rank Sector Weight
1 Healthcare 19.99%
2 Consumer Discretionary 12.3%
3 Technology 11.57%
4 Communication Services 10.98%
5 Financials 9.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
COP icon
551
ConocoPhillips
COP
$147B
$3.39M 0.02%
67,597
-50,960
-43% -$2.35M
RMD icon
552
ResMed
RMD
$28.3B
$3.37M 0.02%
+54,322
New +$3.33M
GK
553
DELISTED
G&K Services Inc
GK
$3.33M 0.02%
34,506
+24,394
+241% +$2.33M
SCCO icon
554
Southern Copper
SCCO
$141B
$3.32M 0.02%
111,995
+46,415
+71% +$1.31M
BZUN
555
Baozun
BZUN
$144M
$3.31M 0.02%
+274,003
New +$3.95M
PHG icon
556
Philips
PHG
$25.4B
$3.3M 0.02%
+145,917
New +$3.18M
MSFT icon
557
Microsoft
MSFT
$2.84T
$3.25M 0.02%
52,346
-97,338
-65% -$5.85M
WWW icon
558
Wolverine World Wide
WWW
$1.54B
$3.24M 0.02%
+147,628
New +$3.35M
ISRG icon
559
Intuitive Surgical
ISRG
$121B
$3.24M 0.02%
45,963
+8,172
+22% +$601K
JONE
560
DELISTED
Jones Energy, Inc.
JONE
$3.23M 0.02%
+35,160
New +$2.85M
WGL
561
DELISTED
Wgl Holdings
WGL
$3.17M 0.02%
+41,508
New +$2.79M
ACH
562
Accendra Health
ACH
$240M
$3.16M 0.02%
+89,427
New +$3.02M
USNA icon
563
Usana Health Sciences
USNA
$394M
$3.12M 0.02%
51,019
-7,061
-12% -$460K
RHI icon
564
Robert Half
RHI
$3.61B
$3.12M 0.02%
63,932
-107,951
-63% -$4.62M
SCACU
565
DELISTED
Saban Capital Acquisition Corp. Units
SCACU
$3.11M 0.02%
300,000
PDCO
566
DELISTED
Patterson Companies, Inc.
PDCO
$3.1M 0.02%
+75,490
New +$3.26M
TXT icon
567
Textron
TXT
$16.6B
$3.04M 0.02%
62,706
+12,843
+26% +$560K
KTWO
568
DELISTED
K2M Group Holdings, Inc
KTWO
$3M 0.02%
+149,721
New +$2.84M
CHD icon
569
Church & Dwight Co
CHD
$23.1B
$2.99M 0.02%
67,671
+295
+0.4% +$13.4K
ZNGA
570
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
$2.98M 0.02%
1,158,889
+618,234
+114% +$1.74M
VOYA icon
571
Voya Financial
VOYA
$8.94B
$2.97M 0.02%
75,682
-417,762
-85% -$14.7M
MRT
572
DELISTED
MedEquities Realty Trust, Inc.
MRT
$2.97M 0.02%
267,262
-471,615
-64% -$5.27M
FDC
573
DELISTED
First Data Corporation
FDC
$2.97M 0.02%
209,009
+105,161
+101% +$1.49M
NRG icon
574
NRG Energy
NRG
$29.8B
$2.96M 0.02%
241,239
-104,170
-30% -$1.2M
VTRS icon
575
Viatris
VTRS
$20.1B
$2.91M 0.02%
+76,357
New +$2.84M

Similar funds

Marshall Wace's Q4 2016 Portfolio in Review

As of Q4 2016, Marshall Wace held 1,269 positions worth $15.2B, up 8.1% from $14.1B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Marshall Wace deployed $754M of net new capital in Q4 2016, opening 352 new positions and adding to 317 existing holdings. Its largest new stake was Texas Instruments: 1,581,130 shares worth $115M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was Zoetis, an estimated $221M trimmed.

  • Marshall Wace's largest Q4 2016 buy was Texas Instruments: 1,581,130 shares worth $115M.
  • Marshall Wace added most to Amazon in Q4 2016, an estimated $124M increase.
  • Marshall Wace's biggest Q4 2016 reduction was Zoetis, cutting an estimated $221M.
  • Marshall Wace fully exited iShares MSCI Emerging Markets ETF in Q4 2016, selling an estimated $240M.
  • Marshall Wace's ten largest holdings make up 16% of its $15.2B portfolio in Q4 2016.
  • Marshall Wace opened 352 new positions and closed 320 in Q4 2016.
  • Marshall Wace's portfolio value rose 8.1% quarter-over-quarter to $15.2B.

Based on Marshall Wace's 13F filing for Q4 2016, filed 10 Feb 2017.